MeSH tree: C04.557.470.615
Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as "reassuring" in a presentation at the 15th European Breast Cancer Conference (EBCC15) in Barcelona.
Mar 26, 2026
0
6
Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published in JAMA Network Open, analyzed ...
Mar 10, 2026
0
15
University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under ...
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.
Oct 29, 2025
0
29
A retrospective study found that the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma ...
Oct 1, 2025
0
20
A study published in the International Journal of Radiation Oncology*Biology*Physics demonstrates that clinicopathology (CP) based risk assessment frequently fails to accurately assess recurrence risk and radiation therapy ...
Jul 31, 2025
0
17
Benign and cancerous calcium phosphate deposits that may look identical on a mammogram have distinct differences in their structures and formation processes, according to researchers at the University of Illinois Urbana-Champaign ...
Jul 22, 2025
0
23
Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely hard to detect, but is now made easier ...
Jun 2, 2025
0
23
A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.
May 29, 2025
0
32
For women at higher risk of breast cancer, there is a proven way to cut the risk in half: take an anti-cancer drug such as tamoxifen.
May 29, 2025
0
14
